Target intelligence / Profile preview

MYC promoter G-quadruplex (MYC G4)

Target
MYC G4
Molecular classification
Non-canonical DNA structure, Nucleic acid, G-quadruplex
01

Overview

The MYC promoter G-quadruplex is a non-canonical, four-stranded DNA structure formed within the nuclease hypersensitive element III1 (NHE III1) of the MYC (c-MYC) oncogene promoter [NIH, 2015; ResearchGate, 2024]. This structure consists of stacked guanine tetrads stabilized by monovalent cations and acts as a critical molecular switch for transcriptional regulation [NIH, 2021; ResearchGate, 2024]. Under normal physiological conditions, the formation of the G-quadruplex serves as a transcriptional silencer by physically obstructing RNA polymerase and displacing activating transcription factors like Sp1 [NIH, 2015; MDPI, 2023]. In many cancers, MYC is overexpressed due to the resolution of this structure by proteins such as NM23-H2, driving uncontrolled cell proliferation and survival [NIH, 2015; NIH, 2023]. Therapeutic strategies focus on using small-molecule ligands to stabilize the G-quadruplex, thereby repressing MYC transcription and inducing apoptosis in cancer cells [MDPI, 2023; NIH, 2023]. However, achieving high selectivity for the MYC G-quadruplex over thousands of other G-quadruplexes in the genome remains a significant challenge in drug development [MDPI, 2023; NIH, 2024].

Other names
Nuclease hypersensitive element III1NHE III1Pu27Pu22c-MYC G-quadruplexMYC G4 DNA
02

Mechanism of action

Stabilization of the G-quadruplex structure within the nuclease hypersensitive element III1 (NHE III1) of the MYC promoter, which physically blocks the transcriptional machinery and displaces activating transcription factors, leading to the downregulation of MYC oncogene expression [NIH, 2015; MDPI, 2023].

03

Biological functions

Transcriptional regulationGene expression controlTranscriptional silencing
04

Disease associations

CancerBurkitt lymphomaBreast cancerColon cancerLeukemiaLymphoma
05

Safety considerations

Off-target binding to other genomic G-quadruplexes [MDPI, 2023]Genomic instability [NIH, 2024]Lack of selectivity over duplex DNA [MDPI, 2023]Potential for unintended transcriptional modulation of other genes [NIH, 2024]
06

Interacting drugs

Quarfloxin (CX-3543)

8 more in the full profile.

07

Biomarkers

MYC mRNA expression levels [NIH, 2021]MYC protein levels [NIH, 2021]G-quadruplex stabilization (detected by fluorescent probes like BMVC) [MDPI, 2023]

Beyond the preview

Go deeper on MYC promoter G-quadruplex (MYC G4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MYC promoter G-quadruplex (MYC G4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call